Kelly J Gaffney

8PUBLICATIONS
7CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 03, 2024
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.

Kelly J Gaffney, Jonathan K Bakos, Arash Velayati

|Apr 25, 2023
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.

Kelly J Gaffney, James A Davis, Mary McGann

|Feb 13, 2023
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma.

Katelynn Granger, Kelly J Gaffney, James A Davis

|Feb 04, 2023
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period.

Kelly J Gaffney, Theresa A Urban, Mariana Lucena

|Jul 05, 2022
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant.

Abigail Shockley, James A Davis, Kelly J Gaffney

|Jun 08, 2022
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring.

Kelly J Gaffney, Theresa A Urban, Mariana Lucena

Pageof 2

Frequent Collaborators

5 joint publications

James A Davis

4 joint publications

Hamza Hashmi

1 joint publications

Robert M Dean

1 joint publications

Abigail Shockley